Researchers at New York's Aaron Diamond AIDS Research Center have teamed with scientists and health officials in China's Yunan province, home to 35 million people, to develop China's largest HIV/AIDS treatment program, the South China Morning Post reports. The three-year project aims to offer antiretroviral drug therapy to about 300 HIV-positive people in the province. Currently, only about 250 people in the entire nation are taking anti-HIV drugs, according to Yunan health officials. Program participants will be given GlaxoSmithKline's once-a-day anti-HIV drug Trizivir, which contains AZT, 3TC, and Ziagen. The pharmaceutical company will donate the medication for the program.